DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹8.00 Cr | ₹8.00 Cr | ₹257 Cr | ₹89 Cr | ₹89 Cr |
What is the latest Contingent Liabilities ratio of DIVIS LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹8.00 Cr |
| Mar2025 | ₹8.00 Cr |
| Mar2024 | ₹257 Cr |
| Mar2023 | ₹89 Cr |
| Mar2022 | ₹89 Cr |
How is Contingent Liabilities of DIVIS LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹8.00 Cr | 0.00 | |
| Mar2025 | ₹8.00 Cr | -96.89 | |
| Mar2024 | ₹257 Cr | 188.76 | |
| Mar2023 | ₹89 Cr | -0.03 | |
| Mar2022 | ₹89 Cr | - | |
Compare Contingent Liabilities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹196,118.2 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| MANKIND PHARMA | ₹105,068.0 Cr | 1.2% | 6.6% | -5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 0.6% |
8.7% |
7.9% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses